Recombinant adenovirus vector vaccine generates mucosal anti

In a recent study posted to the bioRxiv* server, researchers assessed the immunogenicity of the self-developed recombinant adenovirus vector (rAd5) vaccine on macaques. They evaluated the efficacy of three candidate vaccines, ED88, ED90, and ED94, to select the most appropriate one for future development.

Related Keywords

Wuhan , Hubei , China , , Mucosal Immunization , Cynomolgus Macaques , Serum Antibody , Image Credit , Deltas Specific , Adenovirus , Antibodies , Coronavirus Disease Covid 19 , Ars Cov 2 , Vaccine , Ce2 , Ntibody , Ntigen , Covid 19 , Efficacy , Immunity , Immunization , Protein , Espiratory , Evere Acute Respiratory , Evere Acute Respiratory Syndrome , Yndrome ,